Evaluation of COVID-19 cases who received immunosuppressive therapy at a tertiary care hospital
Klimik Dergisi
; 35(1):6-13, 2022.
Article
in Turkish
| GIM | ID: covidwho-1819122
ABSTRACT
Objective:
Immunosuppressive drugs are included in the treatment protocols of severe COVID-19 cases that may present with cytokine storm. In this study, we aimed to examine the characteristics of COVID-19 patients who received immunosuppressive therapyMethods:
Patients diagnosed with COVID-19 and followed in the quarantine wards of our hospital between 01.03.2020-24.05.2020 were included in the study. Patient information was obtained retrospectively from patient files and discharge reports, and 263 COVID-19 patients -aged 18 and over- were included in the study.
9007-41-4; 9007-73-2; viral diseases; coronavirus disease 2019; human diseases; patients; pandemics; antiviral agents; C-reactive protein; chronic diseases; cytokines; drug therapy; ferritin; health care; thrombocytopenia; immunosuppressive agents; Severe acute respiratory syndrome coronavirus 2; man; Severe acute respiratory syndrome-related coronavirus; Betacoronavirus; Coronavirinae; Coronaviridae; Nidovirales; positive-sense ssRNA Viruses; ssRNA Viruses; RNA Viruses; viruses; Homo; Hominidae; primates; mammals; vertebrates; Chordata; animals; eukaryotes; SARS-CoV-2; viral infections; antivirals; chemotherapy; immunosuppressants
Full text:
Available
Collection:
Databases of international organizations
Database:
GIM
Type of study:
Experimental Studies
Language:
Turkish
Journal:
Klimik Dergisi
Year:
2022
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS